Key result
Molecular autopsy and familial cardiological evaluation are supported by recent genetic studies for identifying at-risk family members of sudden arrhythmic death syndrome cases.
This review highlights the importance of familial cardiological evaluation and molecular autopsy in identifying genetic risks in families affected by sudden arrhythmic death syndrome.
Answers are grounded in this paper and cite their sources.
Supports molecular autopsy and familial evaluation in SADS families; leaves open need for prospective validation before routine adoption.
PURPOSE OF REVIEW: Unexplained sudden death and the sudden arrhythmic death syndrome (SADS) affect a small but significant proportion of young and apparently healthy individuals. This review revisits the causes underlying such deaths and the investigational strategies that identify surviving family who may be at risk. RECENT FINDINGS: Recent epidemiological data is available from case series or government records. The yield from familial cardiological evaluation for inherited conditions has been supported by additional small series. The greatest advance has come with molecular autopsy studies, which have utilized various methodologies and candidate genes to investigate SADS cases and their families. SUMMARY: The latest research replicates and extends the existing knowledge regarding epidemiology and familial evaluation of SADS, whilst genetic studies support a role for the molecular autopsy.
No takes yet. Share an insight, caveat, or question.
Raju et al. (2012) conducted a review in Unexplained sudden death and sudden arrhythmic death syndrome (SADS). Molecular autopsy and familial evaluation was evaluated. Molecular autopsy and familial cardiological evaluation are supported by recent genetic studies for identifying at-risk family members of sudden arrhythmic death syndrome cases.
Synapse has enriched 10 related papers. Consider them for comparative context: